MSOS Stock Analysis as cannabis stocks & MSOS stock rally on the dips

Edaravone shows promise in targeting brain tumor stem cells

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

October 17, 2024

Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

July 28, 2024

What we owe ALS patients — and why one company fell short

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.